IDK if it's a "superior" opinion...but it's consistent with PC medical professionals, which ignores novice shooting-from-the-hip.
I guess that you didn't notice this is a modified dose escalation study, all
below the King/UCLA protocol for primary prostate SBRT treatment. They are aware that the prostate won't quite turn to mush with these low doses, but they want to see how mushy it gets. So your linkage to post-RT salvage RP is moot/not relevant.
BTW, there ARE a few surgeons who will carefully select appropriate patients to do RP by hand
after the full-dosage, primary RT treatment (again,
not the same concept as the OP's posting). You'll typically only find surgeons willing to do salvage RP post-RT at specialized medial centers. Most surgeons will not attempt it because of the much higher risk of complications and intra-operative injuries, but a few will. After primary radiation, when a surgeon goes in to take the prostate out, he sees a large ball of scar tissue that the bladder, rectum and prostate are in there somewhere but it's hard to distinguish the 3...the tissue planes (separating organs) are obliterated from typical external RT treatments. Too aggressive and you damage bladder and/or rectum; too conservative and you leave behind tissue containing cancer. Complete loss of erectile function and long-term incontinence are commonplace after SRP. Good luck with that!
Bigger picture: Patients who "fail" RT (using Phoenix definition of nadir+2) have only a small chance (according to Eastman, who does SRP) of local-only recurrence which could be "cured" by a local-only surgical procedure.
So, this (in
red) is certainly not even close to being correct (or well thought-out):
JNF said...
And now lets discuss the nearly universal statement surgeons say to prospective patients that when surgery fails we can use salvage radiotherapy to try again to cure, but if initial radiation fails you can’t then have surgery. I guess this study sure puts thousands of surgeons at odds with their previous advice.
The nearly universal statement remains substantially intact.
BTW, another set of doctors (Glicksman, et al, including Klotz) tried this more than 15-years ago (2001 to 2004; PreORT study), but they included unfavorable-intermediate risk patients in addition to high risk PC patients...same 25 Gy delivered in 5 consecutive 5 Gy fractions, followed by RP 14 days later.
These doctors
just published (May 2019) the long-term toxicity results which reported “unexpected high rates of late GU toxicity,” ie.
radiation late-term side effects. They went on to say that “future studies examining the role of RT preradical prostatectomy must cautiously select RT technique and dose schedule [purpose of the current study]. Importantly,
long-term follow-up data are essential [to gauge late-term RT effects] to fully determine the therapeutic index of PreORT in the management of localized disease.”
So they concluded too many late-GU toxicity issues...but maybe for the higher-risk patients that's an acceptable trade off. As Fairwind has said, “..You get braver as your options dwindle." It's my hope that with 15 years of additional institutional knowledge, the current results might show improvement.
Post Edited (Blackjack) : 8/1/2019 2:42:50 PM (GMT-6)